1-anilino-8-naphthalenesulfonate has been researched along with Glucose Intolerance in 16 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The activity and mass of lipoprotein lipase (LPL) in postheparin plasma (PHP) from patients with hypertriglyceridemia coupled with hypertension, impaired glucose tolerance, hyperinsulinemia were investigated in order to clarify the cause of hypertriglyceridemia and the effects of bezafibrate (CAS 41859-67-0), a novel lipid lowering agent." | 7.69 | Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia. ( Fukamachi, I; Hashimoto, H; Kobayashi, J; Niihara, K; Saito, Y; Sasaki, N; Shirai, K; Takahashi, K; Tashiro, J; Yoshida, S, 1994) |
| " In addition HF-fed rats developed hyperleptinemia and insulinemia as well as insulin resistance and glucose intolerance." | 3.79 | Dietary supplementation with Agaricus blazei murill extract prevents diet-induced obesity and insulin resistance in rats. ( Cani, PD; Delzenne, NM; Denom, J; Everard, A; Kassis, N; Magnan, C; Migrenne, S; Philippe, E; Rouch, C; Takeda, Y; Uchiyama, S; Vincent, M, 2013) |
| "The activity and mass of lipoprotein lipase (LPL) in postheparin plasma (PHP) from patients with hypertriglyceridemia coupled with hypertension, impaired glucose tolerance, hyperinsulinemia were investigated in order to clarify the cause of hypertriglyceridemia and the effects of bezafibrate (CAS 41859-67-0), a novel lipid lowering agent." | 3.69 | Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia. ( Fukamachi, I; Hashimoto, H; Kobayashi, J; Niihara, K; Saito, Y; Sasaki, N; Shirai, K; Takahashi, K; Tashiro, J; Yoshida, S, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A | 1 |
| Balakrishnan, B | 1 |
| Karki, S | 1 |
| Slayton, M | 1 |
| Jash, S | 1 |
| Banerjee, S | 1 |
| Grahn, THM | 1 |
| Jambunathan, S | 1 |
| Disney, S | 1 |
| Hussein, H | 1 |
| Kong, D | 1 |
| Lowell, BB | 1 |
| Natarajan, P | 1 |
| Reddy, UK | 1 |
| Gokce, N | 1 |
| Sharma, VM | 1 |
| Puri, V | 1 |
| Urbizo-Reyes, U | 2 |
| Liceaga, AM | 2 |
| Reddivari, L | 2 |
| Li, S | 2 |
| Kim, KH | 2 |
| Cox, AD | 2 |
| Anderson, JM | 2 |
| Neier, K | 1 |
| Cheatham, D | 1 |
| Bedrosian, LD | 1 |
| Gregg, BE | 1 |
| Song, PXK | 1 |
| Dolinoy, DC | 1 |
| Li, J | 1 |
| Gong, L | 1 |
| Liu, S | 1 |
| Zhang, Y | 2 |
| Zhang, C | 2 |
| Tian, M | 1 |
| Lu, H | 1 |
| Bu, P | 1 |
| Yang, J | 1 |
| Ouyang, C | 1 |
| Jiang, X | 1 |
| Wu, J | 1 |
| Min, Q | 1 |
| Zhang, W | 1 |
| Ayyappa, KA | 1 |
| Ghosh, S | 2 |
| Mohan, V | 1 |
| Radha, V | 1 |
| Vincent, M | 1 |
| Philippe, E | 1 |
| Everard, A | 1 |
| Kassis, N | 1 |
| Rouch, C | 1 |
| Denom, J | 1 |
| Takeda, Y | 1 |
| Uchiyama, S | 1 |
| Delzenne, NM | 1 |
| Cani, PD | 1 |
| Migrenne, S | 1 |
| Magnan, C | 1 |
| Tang, T | 1 |
| Abbott, MJ | 1 |
| Ahmadian, M | 1 |
| Lopes, AB | 1 |
| Wang, Y | 1 |
| Sul, HS | 1 |
| Gottlieb, S | 1 |
| Rand, JS | 1 |
| Marshall, R | 1 |
| Morton, J | 1 |
| Andrés-Blasco, I | 1 |
| Herrero-Cervera, A | 1 |
| Vinué, Á | 1 |
| Martínez-Hervás, S | 1 |
| Piqueras, L | 1 |
| Sanz, MJ | 1 |
| Burks, DJ | 1 |
| González-Navarro, H | 1 |
| Wei, E | 1 |
| Ben Ali, Y | 1 |
| Lyon, J | 1 |
| Wang, H | 1 |
| Nelson, R | 1 |
| Dolinsky, VW | 1 |
| Dyck, JR | 1 |
| Mitchell, G | 1 |
| Korbutt, GS | 1 |
| Lehner, R | 1 |
| Chen, H | 1 |
| Iglesias, MA | 1 |
| Caruso, V | 1 |
| Morris, MJ | 1 |
| Bie, J | 1 |
| Zhao, B | 1 |
| Marqueen, KE | 1 |
| Wang, J | 1 |
| Szomju, B | 1 |
| Sumara, G | 1 |
| Sumara, O | 1 |
| Kim, JK | 1 |
| Karsenty, G | 1 |
| Todorova, B | 1 |
| Kubaszek, A | 1 |
| Pihlajamäki, J | 1 |
| Lindström, J | 1 |
| Eriksson, J | 1 |
| Valle, TT | 1 |
| Hämäläinen, H | 1 |
| Ilanne-Parikka, P | 1 |
| Keinänen-Kiukaanniemi, S | 1 |
| Tuomilehto, J | 1 |
| Uusitupa, M | 1 |
| Laakso, M | 1 |
| Kobayashi, J | 1 |
| Takahashi, K | 1 |
| Tashiro, J | 1 |
| Shirai, K | 1 |
| Saito, Y | 1 |
| Yoshida, S | 1 |
| Hashimoto, H | 1 |
| Fukamachi, I | 1 |
| Niihara, K | 1 |
| Sasaki, N | 1 |
| Garagorri, JM | 1 |
| Rodríguez, G | 1 |
| Ros, L | 1 |
| Sánchez, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Finnish Diabetes Prevention Study: A Follow-up Study on the Effect of a Dietary and Exercise Intervention in the Prevention of Diabetes and Its Vascular Complications[NCT00518167] | 522 participants (Actual) | Interventional | 1993-11-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 1-anilino-8-naphthalenesulfonate and Glucose Intolerance
| Article | Year |
|---|---|
The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
Topics: Alleles; Diabetes Mellitus, Type 2; Disease Progression; Exercise; Female; Genetic Predisposition to | 2004 |
15 other studies available for 1-anilino-8-naphthalenesulfonate and Glucose Intolerance
| Article | Year |
|---|---|
Human CIDEC transgene improves lipid metabolism and protects against high-fat diet-induced glucose intolerance in mice.
Topics: Animals; Cholesterol; Diet, High-Fat; Fatty Acids, Nonesterified; Glucose; Glucose Intolerance; Huma | 2022 |
Canary Seed (
Topics: Animals; Diet, High-Fat; Diet, Western; Glucose Intolerance; Lipase; Liver; Mice; Mice, Inbred C57BL | 2022 |
Canary Seed (
Topics: Animals; Diet, High-Fat; Diet, Western; Glucose Intolerance; Lipase; Liver; Mice; Mice, Inbred C57BL | 2022 |
Canary Seed (
Topics: Animals; Diet, High-Fat; Diet, Western; Glucose Intolerance; Lipase; Liver; Mice; Mice, Inbred C57BL | 2022 |
Canary Seed (
Topics: Animals; Diet, High-Fat; Diet, Western; Glucose Intolerance; Lipase; Liver; Mice; Mice, Inbred C57BL | 2022 |
Longitudinal Metabolic Impacts of Perinatal Exposure to Phthalates and Phthalate Mixtures in Mice.
Topics: Adipokines; Animals; Body Composition; Caenorhabditis elegans Proteins; Dibutyl Phthalate; Diethylhe | 2019 |
Adipose HuR protects against diet-induced obesity and insulin resistance.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Cell Enlargement; Diet, High-Fat; ELAV-L | 2019 |
Association of hepatic lipase gene polymorphisms with hypertriglyceridemia and low high-density lipoprotein-cholesterol levels among South Indian subjects without diabetes.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Fem | 2013 |
Dietary supplementation with Agaricus blazei murill extract prevents diet-induced obesity and insulin resistance in rats.
Topics: Agaricus; Animals; Biomarkers; Blood Glucose; Body Composition; Calorimetry, Indirect; Diet, High-Fa | 2013 |
Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells.
Topics: Animals; Blood Glucose; Cells, Cultured; Diet, High-Fat; Fatty Acids; Glucose; Glucose Intolerance; | 2013 |
Glycemic status and predictors of relapse for diabetic cats in remission.
Topics: Adrenal Cortex Hormones; Aging; Animals; Blood Glucose; Cat Diseases; Cats; Diabetes Mellitus; Femal | 2015 |
Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
Topics: Animals; Blood Glucose; Chemokine CCL2; Diet, High-Fat; Dyslipidemias; Glucose Intolerance; Inflamma | 2015 |
Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure.
Topics: Animals; Apolipoproteins B; Down-Regulation; Eating; Energy Metabolism; Fatty Acids; Glucose; Glucos | 2010 |
Maternal cigarette smoke exposure contributes to glucose intolerance and decreased brain insulin action in mice offspring independent of maternal diet.
Topics: Adiposity; Animals; Blotting, Western; Body Weight; Brain; Carnitine O-Palmitoyltransferase; Diet, H | 2011 |
Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.
Topics: Animals; Basal Metabolism; Dyslipidemias; Glucose Intolerance; Hepatitis; Insulin Resistance; Kupffe | 2012 |
Gut-derived serotonin is a multifunctional determinant to fasting adaptation.
Topics: Adaptation, Physiological; Adipocytes; Animals; Diet, High-Fat; Fasting; Gastrointestinal Tract; Glu | 2012 |
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Female; Glucose Intolerance; Humans; Hyperinsulinism; Hyper | 1994 |
Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Female; Glucose; | 2001 |